Overview

Cardiovascular disease (CVD) is the world's leading cause of death, underscoring the priority to develop and deliver education to improve care and outcome for individuals with CVD.

Cardiovascular Update 2024 will incorporate the latest science, clinical evidence-base, and best-practices, to improve prevention, care delivery and outcomes for individuals at risk or with existing CVD.   Attendees will receive essential educational content emphasizing cutting edge science, the implementation of evidence-based guidelines, and the promotion of health equity among diverse populations, ensuring improved cardiovascular outcomes for all patients.

Objectives

After completing this educational activity, participants will be able to do the following:

• Reduce cardiovascular risks through optimal management of dyslipidemia, hypertension, diabetes, and obesity. 
• Address the issues associated with primary prevention therapy in specific populations including women and the elderly.
• Describe innovations in diagnostic modalities and their clinical use to screen, diagnose, and treat patients with cardiovascular disease.
• Apply recent evidence on mitral regurgitation, cardiac murmurs, and aortic stenosis into clinical decision making for patients with structural heart disease.
• Employ evidence-based therapies and consensus guidelines for the diagnosis, evaluation, and management across the entire spectrum of patients with heart failure and cardiomyopathy.
• Utilize current evidence and guideline recommendations to detect and manage patients with cardiac arrhythmias.

Target Audience

Providers who care for patients at risk for CVD and those with acute and chronic cardiovascular conditions, including general cardiologists, internal medicine specialists, primary care providers, family physicians, residents, fellows, nurse practitioners, physician assistants, nurses, and pharmacists.